When implanted in living tissue, Interface undergoes a time-dependent surface modification. The surface modification reaction results in the formation of a calcium phosphate layer, which is equivalent in composition and structure to the hydroxyapatite found in bone mineral. The biological apatite layer of the granules provides an osteoconductive scaffold for the generation of new osseous tissue. New bone infiltrates around the granules allowing the repair of the defect as the granules are absorbed.

Features

• Supplied as irregular synthetic bioglass granules sized from 200-420 microns
• Elemental composition of Si, Ca, Na and P
• Conforms to ASTM specification F1538 for 45S5 bioactive glass
• Convenient packaging
• Packed in a sterile, single-use vial
• Hermetically sealed foil pouch ensures product sterility before implantation
• Patented Technology1
• Narrow particle size distribution of 200-420 microns is designed for enhanced performance benefits
• Designed for faster bone fill compared to glass particles with a broader size distribution

BioStructures patented formulation is made of the highest quality bioactive glass and designed for enhanced graft performance with greater handling properties.